Published in Proc Soc Exp Biol Med on April 01, 1974
Colicinogeny and related phenomena. Bacteriol Rev (1975) 3.51
Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.52
Characterization of enterocoliticin, a phage tail-like bacteriocin, and its effect on pathogenic Yersinia enterocolitica strains. Appl Environ Microbiol (2001) 1.21
Interaction with lectins and differential wheat germ agglutinin binding of pyocin 103-sensitive and -resistant Neisseria gonorrhoeae. J Bacteriol (1981) 1.05
Pyocin sensitivity of Neisseria gonorrhoeae and its feasibility as an epidemiological tool. Infect Immun (1977) 1.04
The R-type pyocin of Pseudomonas aeruginosa C is a bacteriophage tail-like particle that contains single-stranded DNA. Infect Immun (1999) 0.99
Effect of environment on sensitivity of Neisseria gonorrhoeae to Pseudomonas aeruginosa bacteriocins. Infect Immun (1980) 0.82
Clinical comparison of a new automated infrared blood culture system with the BACTEC 460 system. J Clin Microbiol (1986) 2.28
In vitro and in vivo characterization of pyocin. J Bacteriol (1967) 1.87
In vivo studies with collagenase from Pseudomonas aeruginosa. Infect Immun (1973) 1.52
The extracellular protease from Pseudomonas aeruginosa exhibiting elastase activity. Can J Microbiol (1967) 1.45
Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci (1987) 1.43
In vivo studies with a toxic fraction of Pseudomonas aeruginosa. Proc Soc Exp Biol Med (1970) 1.38
A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography. Med Phys (2003) 1.31
Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent. Infect Immun (1990) 1.27
Age-related susceptibility to Pseudomonas aeruginosa ocular infections in mice. Infect Immun (1978) 1.23
Heightened resistance of athymic, nude (nu/nu) mice to experimental Pseudomonas aeruginosa ocular infection. Infect Immun (1978) 1.22
Pili and lipopolysaccharide of Pseudomonas aeruginosa bind to the glycolipid asialo GM1. Infect Immun (1994) 1.20
Dominant susceptibility effect on the murine corneal response to Pseudomonas aeruginosa. Proc Soc Exp Biol Med (1983) 1.20
In vivo identification of sialic acid as the ocular receptor for Pseudomonas aeruginosa. Infect Immun (1986) 1.20
Pediatric blood culture evaluation of the BACTEC PEDS Plus and the DuPont Isolator 1.5 systems. Diagn Microbiol Infect Dis (1992) 1.19
Analysis of adhesion, piliation, protease production and ocular infectivity of several P. aeruginosa strains. Curr Eye Res (1991) 1.19
In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa. Infect Immun (1987) 1.19
Pseudomonas eye infections in cyclophosphamide-treated mice. Invest Ophthalmol Vis Sci (1977) 1.18
Genetic control of the murine corneal response to Pseudomonas aeruginosa. Infect Immun (1979) 1.15
Nutritional studies with Pseudomonas aeruginosa grown on inorganic sulfur sources. J Bacteriol (1978) 1.13
Penetration of the unwounded immature mouse cornea and conjunctiva by Pseudomonas: SEM-TEM analysis. Invest Ophthalmol Vis Sci (1980) 1.10
Genetic studies of the murine corneal response to Pseudomonas aeruginosa. Infect Immun (1981) 1.09
Monoclonal antibodies provide protection against ocular Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci (1988) 1.08
In vivo and in vitro toxicity of phospholipase C from Pseudomonas aeruginosa. Toxicon (1992) 1.07
Morphological studies on relaxed and contracted forms of purified pyocin particles. J Bacteriol (1969) 1.05
Membranous inclusions of Pseudomonas aeruginosa. J Bacteriol (1971) 1.03
Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases. Invest Ophthalmol Vis Sci (1986) 1.03
Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys (2000) 1.02
Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice. Ophthalmic Res (1992) 1.02
Platelet aggregation by a phospholipase C from Pseudomonas aeruginosa. Thromb Res (1988) 1.00
In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci (1995) 1.00
Kinetics of serum, tear, and corneal antibody responses in resistant and susceptible mice intracorneally infected with Pseudomonas aeruginosa. Infect Immun (1992) 0.97
Thiosulfate oxidase from an Alcaligenes grown on mercaptosuccinate. Can J Microbiol (1972) 0.97
Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis. Infect Immun (1984) 0.96
Role of complement in murine corneal infection caused by Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci (1983) 0.96
Bone marrow segmentation in leukemia using diffusion and T (2) weighted echo planar magnetic resonance imaging. NMR Biomed (2000) 0.96
Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Cancer J (2001) 0.95
Characterization of the inflammatory response induced by corneal infection with Pseudomonas aeruginosa. J Ocul Pharmacol (1994) 0.95
Paraspinal mass associated with intervertebral disk infection secondary to Moraxella kingii. J Pediatr (1978) 0.94
Experimental studies on hematogenously induced renal damage in the rabbit due to Pseudomonas aeruginosa. Proc Soc Exp Biol Med (1975) 0.93
Taurine catabolism. II. biochemical and genetic evidence for sulfoacetaldehyde sulfo-lyase involvement. Biochim Biophys Acta (1980) 0.93
Further studies on the genetic control of murine corneal response to Pseudomonas aeruginosa. Rev Infect Dis (1984) 0.92
Characterization of Pseudomonas aeruginosa adherence to mouse corneas in organ culture. Infect Immun (1990) 0.92
Catabolism of taurine in Pseudomonas aeruginosa. Biochim Biophys Acta (1979) 0.92
Pseudomonas aeruginosa induced ocular infection. A histological comparison of two bacterial strains of different virulence. Ophthalmic Res (1985) 0.89
Aging alters the phagocytic capability of inflammatory cells induced into cornea. Curr Eye Res (1990) 0.88
In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice. Curr Eye Res (1997) 0.88
Scanning electron microscopy of the normal and experimentally infected ocular surface. Scan Electron Microsc (1984) 0.88
Experimental studies on mice challenged subcutaneously with Pseudomonas aeruginosa. Proc Soc Exp Biol Med (1975) 0.88
Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection. Infect Immun (1991) 0.87
Comparative studies on Pseudomonas aeruginosa endotoxin. Z Allg Mikrobiol (1973) 0.87
Purification and partial characterization of a collagenolytic enzyme from Pseudomonas aeruginosa. Biochim Biophys Acta (1975) 0.87
Murine gastrointestinal tract as a portal of entry in experimental Pseudomonas aeruginosa infections. Infect Immun (1976) 0.87
Characteristics of lytic and non-lytic derived strains of Pseudomonas aeruginosa. Proc Soc Exp Biol Med (1966) 0.86
Kinetics of serum and ocular antibody responses in susceptible mice that received a secondary corneal infection with Pseudomonas aeruginosa. Infect Immun (1993) 0.86
Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci (1995) 0.86
Age-related susceptibility of mice to ocular challenge with Pseudomonas aeruginosa exotoxin A. Infect Immun (1981) 0.86
An atypical presentation of the Fitz-Hugh-Curtis syndrome. J Emerg Med (1990) 0.85
Corneal epithelial glycoproteins exhibit Pseudomonas aeruginosa pilus binding activity. Invest Ophthalmol Vis Sci (1992) 0.85
Bacterial proteases and adherence of Pseudomonas aeruginosa to mouse cornea. Exp Eye Res (1996) 0.84
Expression of cathepsins B, D and L in mouse corneas infected with Pseudomonas aeruginosa. Eur J Biochem (2001) 0.84
Blastomyces dermatitidis treated during pregnancy: report of a case. Am J Obstet Gynecol (1977) 0.84
Nutritional requirements for autoplaque production in AP+ strains of Pseudomonas aeruginosa. Can J Microbiol (1966) 0.84
Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci (2000) 0.83
Microbial growth on mercaptosuccinic acid. Can J Microbiol (1968) 0.83
Partial purification and characterization of chondroitinase from Proteus mirabilis. J Infect Dis (1968) 0.83
Proteinase K decreases Pseudomonas aeruginosa adhesion to wounded cornea. Exp Eye Res (1992) 0.83
Characterization of pseudomonal adherence to unwounded cornea. Invest Ophthalmol Vis Sci (1991) 0.82
Electron microscopic observations of Pseudomonas aeruginosa. Z Allg Mikrobiol (1974) 0.82
Systemic and topical protection studies using Pseudomonas aeruginosa flagella in an ocular model of infection. Curr Eye Res (1992) 0.82
Electron microscopic examination and quantitation of rhapidosomes, viruses and bacteria concentrated at an aqueous-air interface. Prep Biochem (1972) 0.81
Expression of membrane-type matrix metalloproteinases 4, 5, and 6 in mouse corneas infected with P. aeruginosa. Invest Ophthalmol Vis Sci (2001) 0.80
Experimental pulmonary infection of mice by tracheal intubation of Pseudomonas aeruginosa: the use of antineoplastic agents to overcome natural resistance. Can J Microbiol (1977) 0.80
Age alters ADPase positive dendritic (Langerhans) cell response to P. aeruginosa ocular challenge. Curr Eye Res (1986) 0.80
Desquamation of the corneal epithelium in the immature mouse: a scanning and transmission microscopy study. Exp Eye Res (1980) 0.79
Anti-receptor antibodies inhibit Pseudomonas aeruginosa binding to the cornea and prevent corneal perforation. Immunol Cell Biol (1996) 0.79
Immunization with homologous Pseudomonas aeruginosa pili protects against ocular disease. Reg Immunol (1994) 0.78
Microscopic characterization of ocular damage produced by Pseudomonas aeruginosa toxin A. Infect Immun (1981) 0.78
Kinetics of immunoglobulin appearance at the ocular surface. Reg Immunol (1990) 0.78
Experimental Pseudomonas exotoxin A mediated ocular damage in mouse pups: microscopic observations. Ophthalmic Res (1982) 0.77
Immunocytochemical localization of IgA in the mouse cornea. Exp Eye Res (1981) 0.77
Population pharmacokinetics of ceftizoxime in premature newborns. Dev Pharmacol Ther (1993) 0.77
Maternal and paternal alcohol consumption increase offspring susceptibility to Pseudomonas aeruginosa ocular infection. Ophthalmic Res (1989) 0.76
Adenoameloblastoma (odontogenic adenomatoid tumor): report of case. J Oral Surg (1972) 0.76
Use of intravenous immunoglobulin in twin neonates with disseminated coxsackie B1 infection. Clin Pediatr (Phila) (1993) 0.76
Change with age in limbal conjunctival epithelial Langerhans cells. Curr Eye Res (1983) 0.75
Actinlike material in Pseudomonas aeruginosa. Infect Immun (1985) 0.75
Partial purification and characterization of thiosulfate oxidase from Pseudomonas aeruginosa. J Bacteriol (1979) 0.75
Taurine catabolism. III. Evidence for the participation of the glyoxylate cycle. Biochim Biophys Acta (1980) 0.75
Purification and characterization of rhodanese from Acinetobacter calcoaceticus. Can J Microbiol (1980) 0.75
Experimental studies on mice subcutaneously challenged with heat-killed cells of Pseudomonas aeruginosa. Proc Soc Exp Biol Med (1976) 0.75
Aseptic meningitis in a neonate with an oral vesicular lesion. Diagn Microbiol Infect Dis (1985) 0.75
Comparative electron microscopic studies on Pseudomonas aeruginosa endotoxin. Z Allg Mikrobiol (1973) 0.75
The prediction of learning in family therapy training programs*. J Marital Fam Ther (1989) 0.75
Neuroimmunotoxic effects in offspring of paternal alcohol consumption. Prog Clin Biol Res (1990) 0.75